Health Professionals for Responsible Drug Scheduling

United States: Sunil Aggarwal, PhD – Removal of Cannabis from Schedule I of the Controlled Substances Act

The Pharmaceuticalization of Cannabis: Rescheduling proponents suggest cannabis doesn't meet the Controlled Substances Act's extensive criteria for placement in Schedule I. The U.S. Government clings to the stance that cannabis merit’s Schedule I status.

By Michael Bachara, Hemp News Correspondent

United States: Sunil Aggarwal – The Pharmaceuticalization of Cannabis Sunil Aggarwal, PhD, represents a new generation of scientific-minded doctors, leaving cannabis’ negative propaganda behind and fighting for it as a valuable, medicinal plant. His credentials include the Medical and Scientific Advisory Board of Americans for Safe Access (ASA), Health Professionals for Responsible Drug Scheduling, service on the Board of Directors for the American Academy of Cannabinoid Medicine and he is a Seattle Hempfest Core Staff Member.

Syndicate content